Gene · 8564
NIH grants707
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 707
Download this page as JSON| Grant | Title | KMO papers | Newest fiscal year |
|---|---|---|---|
| K08DK106523 | Prognostic Biomarkers in Chronic Kidney Disease | 1 | 2019 |
| K23AG049085 | Sleep loss as a vulnerability factor for inflammation induced depressive symptoms in older women | 1 | 2019 |
| K23DK106448 | Dysregulated Mineral Metabolism and Acute Kidney Injury | 1 | 2019 |
| P01CA091955 | Barrett's Esophagus: Predictors of Progression | 1 | 2019 |
| P30DK090728 | Mayo Translational PKD Center (MTPC) | 1 | 2019 |
| P30DK090868 | Baltimore Polycystic Kidney Disease Research and Clinical Core Center | 1 | 2019 |
| P50AG005146 | Johns Hopkins Alzheimer's Disease Research Center | 1 | 2019 |
| P50AG025688 | Emory Alzheimer's Disease Center | 1 | 2019 |
| P50AG047366 | Stanford Alzheimer's Disease Research Center | 1 | 2019 |
| P50AT008661 | Dietary Botanicals in the Preservation of Cognitive and Psychological Resiliency | 1 | 2019 |
| R01AA018779 | Alcohol and Adenosine-Mediated Glutamate Signaling in Neuro-Glial Interaction | 1 | 2019 |
| R01CA177810 | Modulation of MicroRNAs with Xenobiotics to Target c-Myc | 1 | 2019 |
| R01DK109508 | Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis | 1 | 2019 |
| R01ES024915 | Role of de novo DNMTs in Toxicant Induced Alterations in DNA Methylation | 1 | 2019 |
| R01EY020895 | Progressive Impact of Diabetes on Retinal Neuroprotection by ?-Crystallins | 1 | 2019 |
| R01GM102297 | Understanding the Regulatioin of NAD+Homeostasis and Signaling | 1 | 2019 |
| R01HL126130 | Effects of blood conservation and donor characteristics on transfused patient outcomes in a large community hospital network | 1 | 2019 |
| R01HL128485 | miRNA Regulation of the Mitochondrial Genome | 1 | 2019 |
| R01HL131745 | Hypercapnia and Suppression of Anti-viral Host Defense | 1 | 2019 |
| R01HL142003 | Trans-omics Analysis to Unravel Molecular Underpinnings of Heart, Lung and Blood Disease Risk Factors | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8564/grants?page=17